These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 18579813)

  • 1. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.
    Brooke BS; Habashi JP; Judge DP; Patel N; Loeys B; Dietz HC
    N Engl J Med; 2008 Jun; 358(26):2787-95. PubMed ID: 18579813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atenolol versus losartan in children and young adults with Marfan's syndrome.
    Lacro RV; Dietz HC; Sleeper LA; Yetman AT; Bradley TJ; Colan SD; Pearson GD; Selamet Tierney ES; Levine JC; Atz AM; Benson DW; Braverman AC; Chen S; De Backer J; Gelb BD; Grossfeld PD; Klein GL; Lai WW; Liou A; Loeys BL; Markham LW; Olson AK; Paridon SM; Pemberton VL; Pierpont ME; Pyeritz RE; Radojewski E; Roman MJ; Sharkey AM; Stylianou MP; Wechsler SB; Young LT; Mahony L;
    N Engl J Med; 2014 Nov; 371(22):2061-71. PubMed ID: 25405392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol.
    Mullen MJ; Flather MD; Jin XY; Newman WG; Erdem G; Gaze D; Valencia O; Banya W; Foley CE; Child A
    Trials; 2013 Dec; 14():408. PubMed ID: 24289736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of the effect of angiotensin II receptor blocker versus β-blocker on aortic root growth in paediatric patients with Marfan syndrome.
    Mueller GC; Stierle L; Stark V; Steiner K; von Kodolitsch Y; Weil J; Mir TS
    Heart; 2014 Feb; 100(3):214-8. PubMed ID: 24270746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials.
    Pitcher A; Spata E; Emberson J; Davies K; Halls H; Holland L; Wilson K; Reith C; Child AH; Clayton T; Dodd M; Flather M; Jin XY; Sandor G; Groenink M; Mulder B; De Backer J; Evangelista A; Forteza A; Teixido-Turà G; Boileau C; Jondeau G; Milleron O; Lacro RV; Sleeper LA; Chiu HH; Wu MH; Neubauer S; Watkins H; Dietz H; Baigent C;
    Lancet; 2022 Sep; 400(10355):822-831. PubMed ID: 36049495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations.
    Gambarin FI; Favalli V; Serio A; Regazzi M; Pasotti M; Klersy C; Dore R; Mannarino S; Viganò M; Odero A; Amato S; Tavazzi L; Arbustini E
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):354-62. PubMed ID: 19430350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atenolol versus Losartan in Marfan's Syndrome.
    Mallat Z; Tedgui A
    N Engl J Med; 2015 Mar; 372(10):980. PubMed ID: 25738683
    [No Abstract]   [Full Text] [Related]  

  • 8. Atenolol versus Losartan in Marfan's Syndrome.
    Treasure T; Pepper J; Mohiaddin R
    N Engl J Med; 2015 Mar; 372(10):978-9. PubMed ID: 25738682
    [No Abstract]   [Full Text] [Related]  

  • 9. Atenolol versus Losartan in Marfan's Syndrome.
    Ziganshin BA; Mukherjee SK; Elefteriades JA
    N Engl J Med; 2015 Mar; 372(10):977-8. PubMed ID: 25738681
    [No Abstract]   [Full Text] [Related]  

  • 10. Atenolol versus Losartan in Marfan's Syndrome.
    Lacro RV; Dietz HC; Mahony L
    N Engl J Med; 2015 Mar; 372(10):980-1. PubMed ID: 25738680
    [No Abstract]   [Full Text] [Related]  

  • 11. Meta-analysis Examining the Usefulness of Angiotensin Receptor blockers for the Prevention of Aortic Root Dilation in Patients With the Marfan Syndrome.
    Al-Abcha A; Saleh Y; Mujer M; Boumegouas M; Herzallah K; Charles L; Elkhatib L; Abdelkarim O; Kehdi M; Abela GS
    Am J Cardiol; 2020 Aug; 128():101-106. PubMed ID: 32650901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Of Marfan's syndrome, mice, and medications.
    Bowen JM; Connolly HM
    N Engl J Med; 2014 Nov; 371(22):2127-8. PubMed ID: 25405389
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting TGF-beta and the extracellular matrix in Marfan's syndrome.
    Kalluri R; Han Y
    Dev Cell; 2008 Jul; 15(1):1-2. PubMed ID: 18606132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II blockade in Marfan's syndrome.
    Ahimastos AA; Dart AM; Kingwell BA
    N Engl J Med; 2008 Oct; 359(16):1732; author reply 1733-4. PubMed ID: 18923178
    [No Abstract]   [Full Text] [Related]  

  • 15. Aortic root disease in athletes: aortic root dilation, anomalous coronary artery, bicuspid aortic valve, and Marfan's syndrome.
    Yim ES
    Sports Med; 2013 Aug; 43(8):721-32. PubMed ID: 23674060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric Heart Network Trial of Losartan vs. Atenolol in Children and Young Adults with Marfan Syndrome: Impact on Prescription Practices.
    Robertson DM; Truong DT; Cox DA; Carmichael HL; Ou Z; Minich LL; Williams RV; Selamet Tierney ES
    Pediatr Cardiol; 2023 Mar; 44(3):618-623. PubMed ID: 35902413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medical management of Marfan's syndrome and ascending aortic aneurysms in France: initial assessment].
    Ladouceur M; Weber F; Morin P; Jondeau G
    Arch Mal Coeur Vaiss; 2006 Feb; 99(2):117-22. PubMed ID: 16555694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study.
    Chiu HH; Wu MH; Wang JK; Lu CW; Chiu SN; Chen CA; Lin MT; Hu FC
    Mayo Clin Proc; 2013 Mar; 88(3):271-6. PubMed ID: 23321647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II blockade in Marfan's syndrome.
    van Dijk FS; Meijers-Heijboer H; Pals G
    N Engl J Med; 2008 Oct; 359(16):1733; author reply 1733-4. PubMed ID: 18927954
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictors of Rapid Aortic Root Dilation and Referral for Aortic Surgery in Marfan Syndrome.
    Hoskoppal A; Menon S; Trachtenberg F; Burns KM; De Backer J; Gelb BD; Gleason M; James J; Lai WW; Liou A; Mahony L; Olson AK; Pyeritz RE; Sharkey AM; Stylianou M; Wechsler SB; Young L; Levine JC; Tierney ESS; Lacro RV; Bradley TJ;
    Pediatr Cardiol; 2018 Oct; 39(7):1453-1461. PubMed ID: 29948025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.